Found: 27
Select item for more details and to access through your institution.
Beneficial effects of hepatic cyclooxygenase‐2 expression against cholestatic injury after common bile duct ligation in mice.
- Published in:
- Liver International, 2024, v. 44, n. 9, p. 2409, doi. 10.1111/liv.16004
- By:
- Publication type:
- Article
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 9, p. 1, doi. 10.1038/s41419-020-03003-w
- By:
- Publication type:
- Article
Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Severe Infection: Post Hoc Analysis Is Warranted.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33949-z
- By:
- Publication type:
- Article
Development of Cirrhosis after Chronic Type B Hepatitis: A Clinicopathologic and Follow--up Study of 46 HBeAg--Positive Asymptomatic Patients.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1991, v. 86, n. 5, p. 560
- By:
- Publication type:
- Article
Increased let‐7d‐5p in non‐alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1714, doi. 10.1111/liv.15581
- By:
- Publication type:
- Article
Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2553, doi. 10.1111/liv.14519
- By:
- Publication type:
- Article
Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2182, doi. 10.1111/liv.14571
- By:
- Publication type:
- Article
Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus.
- Published in:
- Advanced Science, 2021, v. 8, n. 11, p. 1, doi. 10.1002/advs.202004168
- By:
- Publication type:
- Article
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00489-2
- By:
- Publication type:
- Article
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
- Published in:
- Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00383-3
- By:
- Publication type:
- Article
Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 1, p. 1, doi. 10.1002/ctm2.275
- By:
- Publication type:
- Article
Research update for articles published in EJCI in 2014.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 10, p. 880, doi. 10.1111/eci.12671
- By:
- Publication type:
- Article
mitochondrial respiratory chain activity--a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1159, doi. 10.1111/apt.17469
- By:
- Publication type:
- Article
Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1131, doi. 10.1111/apt.17434
- By:
- Publication type:
- Article
The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 11/12, p. 1260, doi. 10.1111/apt.15015
- By:
- Publication type:
- Article
Response to Retreatment With Interferon-α Plus Ribavirin in Chronic Hepatitis C Patients Is Independent of the NS5 A Gene Nucleotide Sequence.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 9, p. 2487, doi. 10.1111/j.1572-0241.1999.01381.x
- By:
- Publication type:
- Article
Foxa1 Reduces Lipid Accumulation in Human Hepatocytes and Is Down-Regulated in Nonalcoholic Fatty Liver.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030014
- By:
- Publication type:
- Article
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243590
- By:
- Publication type:
- Article
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 9, p. 1611, doi. 10.1111/jgh.13335
- By:
- Publication type:
- Article
Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.
- Published in:
- European Journal of Clinical Investigation, 2014, v. 44, n. 1, p. 65, doi. 10.1111/eci.12192
- By:
- Publication type:
- Article
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 337, doi. 10.3390/biomedicines11020337
- By:
- Publication type:
- Article
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16991-2
- By:
- Publication type:
- Article
Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
- Published in:
- Liver International, 2015, v. 35, n. 8, p. 1983, doi. 10.1111/liv.12813
- By:
- Publication type:
- Article
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06614-9
- By:
- Publication type:
- Article
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 7, p. 586, doi. 10.1007/s00535-024-02098-8
- By:
- Publication type:
- Article
Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease.
- Published in:
- Aging Cell, 2020, v. 19, n. 8, p. 1, doi. 10.1111/acel.13183
- By:
- Publication type:
- Article